Literature DB >> 820379

Purification and properties of pyruvate kinase from Streptococcus lactis.

V L Crow, G G Pritchard.   

Abstract

The pyruvate kinase (ATP: pyruvate 2-O-phosphotransferase, EC 2.7.1.40) of Streptococcus lactis C10 is activated by fructose 1,6-diphosphate (Fru-1,6-P2), activity being a sigmoidal function of activator concentration. The FDP0.5V (Fru-1,6-P2 concentration giving half-maximal velocity) is markedly increased in the presence of low concentrations of inorganic phosphate; 1 mM phosphate increases the FDP0.5V value 6-fold. Although the intracellular level of Fru-1,6-P2 (12-18 mM) in exponentially growing cells on the medium used is much greater than the FDP0.5V for pyruvate kinase (0.2 mM) as determined in triethanolamine-HCl buffer, a much higher Fru-1,6-P2 concentration may be required to activate the enzyme in vivo to overcome phosphate inhibition. Tris and maleate also inhibit the enzyme. At low concentrations of Fru-1,6-P2 (0.1 mM), reaction rate is a sigmoidal function of both phosphoenolpyruvate and adenosine diphosphate (ADP) concentrations; at near saturating concentrations of activator (1 mM) the response to varying ADP is hyperbolic while the response to varying phosphoenolpyruvate becomes much less sigmoidal. The affinity for both substrates (especially phosphoenolpyruvate) is also increased by increasing the concentration of Fru-1,6-P2. The affinity of the enzyme for guanosine disphosphate (GDP) is 12-13 times that for ADP under the assay conditions used. The Streptococcus lactis pyruvate kinase has a molecular weight of 240000 with a subunit molecular weight of 60000.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 820379     DOI: 10.1016/0005-2744(76)90225-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  The intricate side of systems biology.

Authors:  Eberhard Voit; Ana Rute Neves; Helena Santos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

Review 2.  Biological systems modeling and analysis: a biomolecular technique of the twenty-first century.

Authors:  Gautam Goel; I-Chun Chou; Eberhard O Voit
Journal:  J Biomol Tech       Date:  2006-09

3.  Fructose 1,6-diphosphate-activated L-lactate dehydrogenase from Streptococcus lactis: kinetic properties and factors affecting activation.

Authors:  V L Crow; G G Pritchard
Journal:  J Bacteriol       Date:  1977-07       Impact factor: 3.490

4.  In vivo regulation of glycolysis and characterization of sugar: phosphotransferase systems in Streptococcus lactis.

Authors:  J Thompson
Journal:  J Bacteriol       Date:  1978-11       Impact factor: 3.490

5.  Isolation and Characterization of Phosphoenolpyruvate Phosphatase from Germinating Mung Beans (Vigna radiata).

Authors:  O P Malhotra; A M Kayastha
Journal:  Plant Physiol       Date:  1990-05       Impact factor: 8.340

6.  Use of 31P nuclear magnetic resonance spectroscopy and 14C fluorography in studies of glycolysis and regulation of pyruvate kinase in Streptococcus lactis.

Authors:  J Thompson; D A Torchia
Journal:  J Bacteriol       Date:  1984-06       Impact factor: 3.490

7.  Regulation of product formation during glucose or lactose limitation in nongrowing cells of Streptococcus lactis.

Authors:  A M Fordyce; V L Crow; T D Thomas
Journal:  Appl Environ Microbiol       Date:  1984-08       Impact factor: 4.792

8.  Purification and properties of pyruvate kinase from Streptococcus mutans.

Authors:  K Abbe; T Yamada
Journal:  J Bacteriol       Date:  1982-01       Impact factor: 3.490

9.  Identification of a novel operon in Lactococcus lactis encoding three enzymes for lactic acid synthesis: phosphofructokinase, pyruvate kinase, and lactate dehydrogenase.

Authors:  R M Llanos; C J Harris; A J Hillier; B E Davidson
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

10.  Purification and properties of pyruvate kinase from Streptococcus sanguis and activator specificity of pyruvate kinase from oral streptococci.

Authors:  K Abbe; S Takahashi; T Yamada
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.